News

May 03, 2022

FDA has issued the final guidance on electronic postmarketing safety reports in a series of guidance documents.

May 03, 2022

VYDURA has been granted marketing authorization by the European Commission for both acute treatment of migraine and prophylaxis of episodic migraine.

May 02, 2022

Moderna has filed for emergency use authorization of its COVID-19 vaccine for use in young children six months to under six years of age.

May 02, 2022

A long-running criminal case involving the theft of confidential data from a pharma giant is still unravelling, as more convictions are made.

May 02, 2022

What are the next steps for permanent authorization of COVID-19 vaccines, treatments, and diagnostics?

May 02, 2022

ENHERTU has been granted breakthrough therapy designation in the US for patients with HER2 low metastatic breast cancer.

May 02, 2022

Fresh insight is instrumental in the discussion of novel analytics.

May 02, 2022

FDA has granted regenerative medicine advanced therapy (RMAT) designation to Autolus’ CAR-T cell therapy obe-cel.

May 01, 2022

Spring has returned, and with it comes INTERPHEX.

April 29, 2022

Bio-Rad Laboratories introduces three new fluorescent dyes under the StarBright product range to support multicolor flow cytometry panels.